ReWalk Robotics Ltd. (NASDAQ:RWLK)’s share price traded down 2% on Thursday . The company traded as low as $5.73 and last traded at $5.86, with a volume of 81,431 shares trading hands. The stock had previously closed at $5.98.

A number of equities analysts have weighed in on the stock. Jefferies Group reiterated a “buy” rating and issued a $16.00 price target on shares of ReWalk Robotics in a report on Sunday, May 8th. Zacks Investment Research lowered shares of ReWalk Robotics from a “buy” rating to a “hold” rating in a report on Thursday, July 7th. Piper Jaffray Cos. assumed coverage on shares of ReWalk Robotics in a report on Friday, July 15th. They issued an “overweight” rating and a $10.00 price target on the stock. Finally, Canaccord Genuity reiterated a “buy” rating on shares of ReWalk Robotics in a report on Sunday, August 7th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $12.80.

The firm’s market cap is $72.27 million. The firm’s 50-day moving average is $6.63 and its 200-day moving average is $8.21.

ReWalk Robotics (NASDAQ:RWLK) last announced its quarterly earnings results on Thursday, August 4th. The medical device company reported ($0.64) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.53) by $0.11. The firm had revenue of $0.82 million for the quarter, compared to the consensus estimate of $1.95 million. The company’s revenue for the quarter was up 34.4% on a year-over-year basis. Equities research analysts forecast that ReWalk Robotics Ltd. will post ($2.34) earnings per share for the current fiscal year.

In related news, Director Jeff Dykan sold 11,370 shares of the company’s stock in a transaction on Wednesday, June 1st. The shares were sold at an average price of $7.74, for a total transaction of $88,003.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Scp Vitalife Partners (Israel) sold 4,772 shares of the company’s stock in a transaction on Friday, June 3rd. The stock was sold at an average price of $7.89, for a total transaction of $37,651.08. The disclosure for this sale can be found here.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.